It has been suggested that probiotics could reduce the incidence of infectious complications in patients with severe acute pancreatitis. This well-designed RCT showed an increased mortality in ...

Pancreatitis in children, often mistaken for minor digestive issues, can cause severe abdominal pain and requires timely ...

USA: A study published in Digestive and Liver Disease suggests that youths who experience acute pancreatitis may face an ...

A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a groundbreaking approach to improving patient outcomes.

The FDA approved olezarsen (Tryngolza) as the first drug for adults with familial chylomicronemia syndrome, a rare genetic ...

A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a ...

US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet: Carlsbad, California Monday, December 23, 2024, 15: ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA™ (olezarsen) as an adjunct to diet to reduce triglycerides in adults ...

APACHE II, Acute Physiology and Chronic Health Evaluation II; AUC, area under the ROC curve; BISAP, Beside Index for Severity in Acute Pancreatitis; ROC, receiver operating characteristics ...

Despite securing the industry’s first approval for familial chylomicronemia syndrome, BMO Capital Markets believes that ...

Ionis Pharmaceuticals Inc. CEO Brett Monia predicted that diagnoses of familial chylomicronemia syndrome (FCS) will ...